Cronos Group Inc vs JPMorgan Diversified Return International Eqty ETF — how do they compare? Cronos Group Inc trades at $3.23 (market cap $1.18B), while JPMorgan Diversified Return International Eqty ETF trades at $73.01 (market cap $378.77M). The key difference: Cronos Group Inc is far larger — about 3.1× JPMorgan Diversified Return International Eqty ETF's market cap, and Cronos Group Inc is trading nearer its 52-week high, JPMorgan Diversified Return International Eqty ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Cronos Group Inc for 22 Days and JPMorgan Diversified Return International Eqty ETF for 120 Days on average.
| CRON | JPIN | |
|---|---|---|
Market Cap | $1.18B | $378.77M |
Volume | 968,037 | 13,861 |
Sector | Health | — |
52-Week High | $3.55 | $77.80 |
52-Week Low | $2.30 | $64.96 |
Typical Hold Time | 22 Days | 120 Days |
Enterprise Value | $387.62M | — |
Signals from Pluang's Aura AI — not financial advice
CRON trades at $3.22, down 0.62% on the day, with a bearish technical signal and neutral oscillators. Revenue grew to $146.59M in 2025, but net income was -$9.45M. Recent Q2 2026 earnings beat expectations with EPS of $0.09. The company held its first Investor Day in September 2026, highlighting international expansion and cash flow focus.
Outlook is mixed: strong revenue growth and a solid balance sheet with no debt support upside, but profitability remains inconsistent. Risks include cash flow volatility and competitive pressures. Analyst consensus is cautious with 60% hold ratings, reflecting uncertainty amid expansion efforts.
JPIN trades at $73.01, showing minimal daily movement with a 0.1% gain. Technical indicators are predominantly bearish, with moving averages and oscillators signaling selling pressure, though RSI levels suggest potential oversold conditions. The ETF, designed for international equity exposure, lacks current fundamental data for valuation ratios and profitability metrics.
The outlook remains cautious due to strong bearish technical signals and absence of recent financial updates. Key risks include market volatility and reliance on international equities. Investors should await earnings reports for fundamental clarity, as current data is insufficient to assess valuation or growth prospects.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Cronos Group, headquartered in Toronto, Canada cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis to Poland and Germany. In addition, it has entered joint ventures in Israel, Colombia, and Australia to drive further international cultivation and distribution growth. In the U.S. the company directly sells hemp-derived CBD and has an option to acquire 10.5% of U.S. multistate operator PharmaCann.
Read more on CRON →The fund will invest at least 80% of its assets in securities included in the underlying index. The underlying index is comprised of equity securities across developed global markets (excluding North America) selected to represent a diversified set of factor characteristics.
Read more on JPIN →